Nurix Therapeutics Inc.

NASDAQ: NRIX · Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
11.00
4.07%
After-hours: Aug 15, 2025, 05:17 PM EDT

Nurix Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 31, 2025 Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Net Income
-43.46M -56.35M -58.55M -48.96M -44.55M -41.52M -41.96M -36.98M -24.28M -40.73M -46.72M -45.71M -45.4M -42.53M -37.7M -28.84M -26.38M -24.27M
Depreciation & Amortization
5.1M 4.13M 4.3M 4.15M 4.09M 3.89M 3.76M 3.38M 3.33M 3.18M 3.04M 2.89M 2.63M 2.25M 4.05M 745K 645K 643K
Stock-Based Compensation
10.38M 8.72M 8.51M 8.75M 8.85M 7.82M 8.02M 8.45M 8.72M 8.48M 8.3M 6.99M 6.78M 6.07M 4.84M 4.31M 3.94M 2.7M
Other Working Capital
10.82M -10.82M -7.14M -3.8M -3.4M -9.28M 52.11M -16.47M -3.06M -19.02M -7.02M -9.79M 569K -8.86M -1.4M -5.46M -11.31M 27.86M
Other Non-Cash Items
-49.21M -3.56M -3.46M -3.42M 17.41M -2.86M 6.93M -1.2M -950K -762K -650K 83K 661K 542K 606K 662K 344K 222K
Deferred Income Tax
n/a n/a n/a n/a n/a 930K -8.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
14.03M -14.03M 449K -2.7M -5.94M -10.21M 53.88M -14.78M -5.3M -18.62M -1.92M -10.56M 2.42M -8.96M -2.71M -6.86M -10.09M 28.76M
Operating Cash Flow
-63.16M -61.09M -48.75M -42.18M -39.7M -41.95M 21.75M -41.13M -18.47M -48.45M -37.95M -46.31M -32.91M -42.63M -30.91M -29.97M -31.54M 8.05M
Capital Expenditures
-2.67M -3.48M -2.1M -2.35M -1.94M -2.88M -2.58M -2.46M -1.08M -2.28M -2.56M -3.42M -2.79M -3.47M -862K -1.86M -2.09M -843K
Cash Acquisitions
n/a n/a n/a 38.4M n/a -38.4M 88.49M -25.23M -44.91M -18.34M -57.57M 59.66M 1.98M n/a n/a n/a n/a n/a
Purchase of Investments
-68.17M -110.18M -298.21M -129.82M -225.12M -54.8M -88.39M -74.59M -60.71M -22.64M -26.91M -132.42M -64.79M -15.24M -90.68M -74.58M -135.5M -47.74M
Sales Maturities Of Investments
142.34M 139.2M 159.5M 110.83M 95.98M 93.2M 76.61M 99.82M 105.62M 40.99M 84.48M 72.77M 62.81M 58.75M 55.02M 64.21M 80.48M 46.2M
Other Investing Acitivies
n/a n/a n/a -38.4M -129.13M 38.4M -88.49M 25.23M 44.91M 18.34M 57.57M -59.66M -1.98M 43.5M -35.66M -10.37M -55.02M -1.54M
Investing Cash Flow
71.5M 25.53M -140.82M -21.34M -131.07M 35.51M -14.37M 22.77M 43.83M 16.07M 55.01M -63.08M -4.76M 40.03M -36.52M -12.23M -57.11M -2.39M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
1.25M n/a n/a 15K -15K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
6K 1.47M 1.45M 3.9M 237.75M 1.62M 7K 1.7M 25K 1.48M -135K 96.01M 432K 1.49M 500K 1.55M 150.47M 1.36M
Financial Cash Flow
6K 1.47M 200.52M 45.77M 237.75M 1.62M 4.95M 1.7M 25K 1.48M -135K 115.41M 432K 1.49M 500K 1.55M 150.47M 1.36M
Net Cash Flow
8.34M -34.08M 10.95M -17.75M 66.98M -4.81M 12.32M -16.65M 25.39M -30.9M 16.92M 6.02M -37.25M -1.11M -66.93M -40.65M 61.83M 7.03M
Free Cash Flow
-65.84M -64.57M -50.86M -44.52M -41.64M -44.84M 19.16M -43.59M -19.55M -50.73M -40.52M -49.73M -35.7M -46.1M -31.77M -31.84M -33.63M 7.21M